Skip to main content
. 2021 Nov 10;6:383. doi: 10.1038/s41392-021-00779-x

Fig. 7.

Fig. 7

Exosomal ncRNA-based therapeutics in human diseases. Endogenous (pre-loading cargoes into donor cells followed by exosomal cargo release) or exogenous (directly loading cargoes into exosomes after their production or isolation) loading of ncRNAs or their inhibitors into exosomes exhibits significant therapeutic potential. ASO antisense oligonucleotide. This figure was created with the aid of Servier Medical Art (https://smart.servier.com/)